RIFT Biotherapeutics' Seed VC Round

RIFT Biotherapeutics raised a round of funding on April 03, 2017. Investors include MPM Capital.

RIFT generates therapeutic antibodies that harness the immune system, to target cancers in areas of high unmet needs.…

Articles about RIFT Biotherapeutics' Seed VC Round: